IgG2 vs. IgG1 glycosylation. Displayed are ratios (IgG2/IgG1) for each glycofeature within the same group and compartment. p adj denotes the p value after Bonferroni correction. IgG2 afucosylation could not be assessed because of overlay with IgG4 glycan structures. (DOC 32Â kb
MS lesion classification. MS lesions are characterized by loss of myelin staining, here visualized b...
Figure S1. PLS-DA was performed on proteomic data. Figure S2. Overlap between proteins detected in C...
Proteins identified in fractions obtained by antibody/Protein G-based depletion (Accession, accessio...
CSF vs. serum IgG2 glycosylation. Afucosylation could only be assessed for IgG1, but not for IgG2, a...
IgG2 glycosylation in CSF and serum from MS patients vs. controls. CSF IgG2 glycosylation (normalize...
Terminal IgG1 sialylation and galactosylation correlate with each other (A), whereas other combinati...
Representative mass spectrometric IgG1 and IgG2 Fc glycosylation data from an MS patient. Tryptic Fc...
Figure S1. The correlation coefficients in independent variables. Statistically significant associat...
Table S1. Comparison of levels of phosphorylated proteins between MS patients and controls in baseli...
Table S4. Comparison of levels of p38MAPK, Erk1/2, STAT1, and STAT6 between MS patients and controls...
Table S3. Comparison of levels of phosphorylated proteins between MS patients and controls after in ...
Demographic characteristics of the nationwide EIRA cohort. Table S2. Characterized complement pathwa...
Table S1. Association between growth differentiation factor 15 (GDF-15) and organ involvements. Tabl...
Table S2. Comparison of fold change of protein phosphorylation between MS patients and controls afte...
Abundance and cut-off values of NG1(6)A2F and NG1(3)A2F in 7 SPE negative and 2 IFE negative IgD MM....
MS lesion classification. MS lesions are characterized by loss of myelin staining, here visualized b...
Figure S1. PLS-DA was performed on proteomic data. Figure S2. Overlap between proteins detected in C...
Proteins identified in fractions obtained by antibody/Protein G-based depletion (Accession, accessio...
CSF vs. serum IgG2 glycosylation. Afucosylation could only be assessed for IgG1, but not for IgG2, a...
IgG2 glycosylation in CSF and serum from MS patients vs. controls. CSF IgG2 glycosylation (normalize...
Terminal IgG1 sialylation and galactosylation correlate with each other (A), whereas other combinati...
Representative mass spectrometric IgG1 and IgG2 Fc glycosylation data from an MS patient. Tryptic Fc...
Figure S1. The correlation coefficients in independent variables. Statistically significant associat...
Table S1. Comparison of levels of phosphorylated proteins between MS patients and controls in baseli...
Table S4. Comparison of levels of p38MAPK, Erk1/2, STAT1, and STAT6 between MS patients and controls...
Table S3. Comparison of levels of phosphorylated proteins between MS patients and controls after in ...
Demographic characteristics of the nationwide EIRA cohort. Table S2. Characterized complement pathwa...
Table S1. Association between growth differentiation factor 15 (GDF-15) and organ involvements. Tabl...
Table S2. Comparison of fold change of protein phosphorylation between MS patients and controls afte...
Abundance and cut-off values of NG1(6)A2F and NG1(3)A2F in 7 SPE negative and 2 IFE negative IgD MM....
MS lesion classification. MS lesions are characterized by loss of myelin staining, here visualized b...
Figure S1. PLS-DA was performed on proteomic data. Figure S2. Overlap between proteins detected in C...
Proteins identified in fractions obtained by antibody/Protein G-based depletion (Accession, accessio...